Advertisement

Polyunsaturated Oils of Marine and Plant Origins and Their Uses in Clinical Medicine

  • David F. Horrobin

Abstract

The two main dietary essential fatty acids (EFAs) are linoleic acid and alpha-linolenic acid (ALA). These two parent fatty acids are metabolized within the body to whar are sometimes called the derived EFAs. The derived EFAs include gamma-linolenic acid (GLA), dihomogammalinolenic acid (DGLA) and arachidonic acid of the n−6 series from linoleic acid, and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) of the n−3 series from ALA. The traditional teaching is that there is no dietary requirement for the derived EFAs. It is assumed that all the amounts of the derived EFAs that are needed can be formed within the body from linoleic acid and ALA.

Keywords

Linoleic Acid Arachidonic Acid Atopic Eczema Diabetic Neuropathy Premenstrual Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hudson, B.J.F., Human Nutrition: Food Sci. Nutr. 41F: 1 (1987)Google Scholar
  2. 2.
    Kummerow, F.A., J. Environ. Path. Toxicol. Chem. 6: 123 (1986)Google Scholar
  3. 3.
    Brenner, R.R., Progr. Lipid Res. 20: 41 (1982)CrossRefGoogle Scholar
  4. 4.
    Garcia, P.T. and Holman, R.T., J. Am. Oil Chem. Soc. 42: 1137 (1965).PubMedCrossRefGoogle Scholar
  5. 5.
    Sprecher, H., Progr. Lipid Res. 20: 13 (1982).CrossRefGoogle Scholar
  6. 6.
    Manku, M.S., Horrobin, D.F., Morse, N.L., Wright, S. and Burton, J.L., Br. J. Dermatol. 110: 643 (1984).PubMedCrossRefGoogle Scholar
  7. 7.
    Strannegard, I.L., Svennerholm, L. and Strannegard, O., Int. Arch. Allergy Appl. Immunol. 82: 423 (1987).Google Scholar
  8. 8.
    Jones, D.B., Carter, R.D., Haitas, B. and Mann, J.I., Br. Med. J. 286: 178 (1983).Google Scholar
  9. 9.
    Tilvis, R.S., Helve, E. and Miettinen, T.A., Diabetologia 29: 690 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    Glen, I., Skinner, F., Glen, E. and MacDonell, L., Alcoholism: Clin. Exp. Res. 11: 37 (1987).CrossRefGoogle Scholar
  11. 11.
    Putnam, J.C., Carlson, S.E., DeVoe, P.W. and Barness, L.A., Am. J. Clin. Nutr. 36: 106, 1982.PubMedGoogle Scholar
  12. 12.
    Miettinen, T.A., Huttunen, J.K., Naukkarinen, V., Monogr. Atherosclerosis 4: 19 (1986).Google Scholar
  13. 13.
    Salonen, J.T., Salonen, R. and Penttila, I., Am. J. Cardiol. 58: 226, (1985).CrossRefGoogle Scholar
  14. 14.
    Wood, D.A., Butler, S. and Riemersma, R.A., Lancet 2: 117 (1984).PubMedCrossRefGoogle Scholar
  15. 15.
    Bates, C. van Dam, C. and Horrobin, D.F., Prostaglandins Leukotr. Med. 17: 77 (1985).Google Scholar
  16. 16.
    Horrobin, D.F., Med. Hypotheses 22: 421 (1987).PubMedCrossRefGoogle Scholar
  17. 17.
    Frankel, T.L. and Rivers, J.P.W., Br. J. Nutr. 39: 227 (1978).PubMedCrossRefGoogle Scholar
  18. 18.
    Manku, M.S., Morse-Fisher, N. and Horrobin, D.F., Eur. J. Clin. Nutr. 42: 55 (1988).PubMedGoogle Scholar
  19. 19.
    Gibson, R.A., Sinclair, A.J., Comp. Biochem. Physiol. 78C: 325 (1984).Google Scholar
  20. 20.
    Qureshi, A.A., Schnoes, H.K., Din, Z.Z. and Peterson, D.M., Fed. Proc. 43: 2626 (1984).Google Scholar
  21. 21.
    Hudson, B.J.F. J. Am. Oil Chem. Soc. 61: 540 (1984).CrossRefGoogle Scholar
  22. 22.
    Traitler, H. and Winter, H., Progr. Lipid Res. 25: 255 (1986).CrossRefGoogle Scholar
  23. 23.
    Wright, S. and Burton, J.L., Lancet 2: 1120 (1982).PubMedCrossRefGoogle Scholar
  24. 24.
    Belch, J.J.F., Ansell, D., Madhok, R., O’Dowd, A. and Sturrock, R.D., Ann. Rheum. Dis. 47: 96 (1988).PubMedCrossRefGoogle Scholar
  25. 25.
    Jamal, G.A., Carmichael, H. and Weir, A.J., Lancet 1: 1098 (1986).PubMedCrossRefGoogle Scholar
  26. 26.
    Glen, E., MacDonnell, L., Glen, I. and MacKenzie, J. Possible pharma-cological approaches to the prevention and treatment of alcohol-related CNS impairment: results of a double blind trial of essential fatty acid, in Pharmacological Treatments for Al oholism, G. Edwards and J. Littleton, eds., Croom Helm, London.Google Scholar
  27. 27.
    Pye, J.K., Mansel, R.E. and Hughes, L.E., Lancet 2: 373 (1985).PubMedCrossRefGoogle Scholar
  28. 28.
    Dayton, S., Hashimoto, S. and Dixon, W. J., Lipid. Res. 7: 103 (1966).Google Scholar
  29. 29.
    Singer, P., Berger, I. & Wirth, M., Prostaglandins Leukotr. Med. 24: 173 (1986).Google Scholar
  30. 30.
    Singer, P., Jaeger, W. and Voigt, S., Prostaglandins Leukotr. Med. 15: 159 (1984).Google Scholar
  31. 31.
    Lasserre, M., Mendy, F. and Spielman, D., Lipids 20: 227–233 (1985).PubMedCrossRefGoogle Scholar
  32. 32.
    Gibson, R.A., Proc. Nutr. Soc. Australia 10: 196 (1985).Google Scholar
  33. 33.
    Vericel, E., Lagarde, M., Mendy, F., Courpron, P. and Dechavanne, M., Nutr. Res. 7: 569 (1987).CrossRefGoogle Scholar
  34. 34.
    Manku, M.S., Morse-Fisher, N. and Horrobin, D.F., Eur. J. Clin. Nutr. 42: 55 (1988).PubMedGoogle Scholar
  35. 35.
    Everett, D.J., Greenough, R.J., Perry, C.J., McDonald, P. and Bayliss, P. Med. Sci. Res. in press.Google Scholar
  36. 36.
    Perry, C.J., Everett, D.J., Macnaughten, F., Howroyd, P. and Bayliss, P., Med. Sci. Res. in press.Google Scholar
  37. 37.
    Schalin-Karrila, M., Mattila, L., Jansen, C.T. and Uotila, P., Br. J. Dermatol. 117: 11, 1987.PubMedCrossRefGoogle Scholar
  38. 38.
    Morse, P.F., Horrobin, D.F., Manku, M.S. and Stewart, J.C.M., Br. J. Dermatol. in press.Google Scholar
  39. 39.
    Poisson, J.P., Enzyme 34: 1 (1985).PubMedGoogle Scholar
  40. 40.
    Horrobin, D.F., Prostaglandins Leukotr. EFAs 31: 181 (1988).Google Scholar
  41. 41.
    Jamal, G.A., Carmichael, H. and Weir, A.J., Lancet 1: 1098 (1986).PubMedCrossRefGoogle Scholar
  42. 42.
    Brush, M.G., Watson, S.J., Horrobin, D.F. and Manku, M.S., Am. J. Obstet. Gynecol. 150: 363 (1984).PubMedGoogle Scholar
  43. 43.
    Puolakka, J., Makarainen, L., Viinikka, L. and Ylikorkala, O. J., Re-prod. Med. 30: 149 (1985).Google Scholar
  44. 44.
    Massil, H., O’Brien, P.M.S. and Brush, M.G., presented at 2nd International Symposium on Premenstrual Syndrome, Kiawah Island, Sept. 1987.Google Scholar
  45. 45.
    Casper, R., presented at 2nd International Symposium on Premenstrual Syndrome, Kiawah Island, Sept. 1987.Google Scholar
  46. 46.
    Oeckermann, P.A., Bachrack, I., Glans, S. and Rassner, S., Rec. Adv. Clin. Nutr. 2: 404 (1986).Google Scholar
  47. 47.
    Horrobin, D.F. J., Reprod. Med. 30: 149 (1985).Google Scholar
  48. 48.
    Horrobin, D.F. and Manku, M.S., presented at 2nd International Symposium on Premenstrual Syndrome, Kiawah Island, Sept. 1987.Google Scholar
  49. 49.
    Kunkel, S.L., Ogawa, H., Ward, P.A. and Zurier, R.B., Progr. Lipid Res. 20: 885, 1981.CrossRefGoogle Scholar
  50. 50.
    Hansen T.M., Lerche, A., Kassis, V., Lorenzen, I. and Sondergaard, J., Scand. J. Rheumatol. 12: 85 (1983).PubMedCrossRefGoogle Scholar
  51. 51.
    Lawson, L.D. and Hughes, B.G., Biochem. Biophys. Res. Comm. 152: 328 (1988).CrossRefGoogle Scholar
  52. 52.
    Myher, J.J., Marai, A., Kuksis, A. and Kritchevsky, D., Lipids 12: 775 (1977).PubMedCrossRefGoogle Scholar
  53. 53.
    Lawson, L.D. and Hughes, B.G., Lipids 23: 313 (1988).CrossRefGoogle Scholar
  54. 54.
    Jenkins, D.K. Mitchell, J.C., Manku, M.S. and Horrobin, D.F., Med. Sci. Res. in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • David F. Horrobin
    • 1
  1. 1.Efamol Research InstituteKentvilleCanada

Personalised recommendations